 | • レポートコード：MRC2303M074 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| モルドールインテリジェンス社の本調査資料によると、世界の神経モニタリング市場規模が、予測期間中に年平均成長率5.1%で拡大すると予測されています。本書は、神経モニタリングの世界市場にフォーカスし、最新動向と今後の市場性などをまとめており、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（磁気共鳴画像装置、脳波装置、脳酸素濃度計、頭蓋内圧モニター、その他）分析、疾患別（外傷性脳損傷、脳卒中、睡眠障害、パーキンソン病、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来の動向などが掲載されています。また、Natus Medical Inc.、Nihon Kohden Corporation、Philips Healthcare、GE Healthcare、Siemens Healthineers、Compumedics Limited、Medtronic PLC、Advanced Brain Monitoring Inc.、Dragerwerk Ag & Co. KGaA、Masimo Corporationなど、主要企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の神経モニタリング市場規模：製品別 - 脳波装置の市場規模 - 脳酸素濃度計の市場規模 - 頭蓋内圧モニターの市場規模 - その他の市場規模の市場規模 ・世界の神経モニタリング市場規模：疾患別 - 外傷性脳損傷における市場規模 - 脳卒中における市場規模 - 睡眠障害における市場規模 - パーキンソン病における市場規模 - その他における市場規模 ・世界の神経モニタリング市場規模：地域別 - 北米の神経モニタリング市場規模 アメリカの神経モニタリング市場規模 カナダの神経モニタリング市場規模 メキシコの神経モニタリング市場規模 … - ヨーロッパの神経モニタリング市場規模 イギリスの神経モニタリング市場規模 フランスの神経モニタリング市場規模 ドイツの神経モニタリング市場規模 … - アジア太平洋の神経モニタリング市場規模 中国の神経モニタリング市場規模 インドの神経モニタリング市場規模 日本の神経モニタリング市場規模 … - 南米/中東の神経モニタリング市場規模 ブラジルの神経モニタリング市場規模 アルゼンチンの神経モニタリング市場規模 南アフリカの神経モニタリング市場規模 … - その他地域の神経モニタリング市場規模 ・競争状況 ・市場機会・将来の動向 |
The neurology monitoring market is poised to witness a CAGR of 5.1% during the forecast period.
COVID-19 had a profound impact on people with neurological disorders. Owing to the pandemic-related restrictions, diagnostics and treatment procedures were impacted, and research activities were halted. For instance, the National Institute of Health data published in April 2021 stated that the estimated incidence of a neurological or psychiatric diagnosis in the following six months was 33.62% among the 236,379 patients diagnosed with COVID-19. Among those diagnosed, 0.56% suffered from intracranial hemorrhage, 2.10% from ischemic stroke, 0.11% from parkinsonism, 0.67% from dementia, 17.39% from an anxiety disorder, and 1.40% from a psychotic disorder. Therefore, with the abovementioned data, it is observed that COVID-19 had a significant impact on the market studied. However, the market is gaining its pre-pandemic demand for neurology monitoring devices, and it is expected to witness healthy growth in the forecast period.
The neurology monitoring market is expected to show rapid growth due to the increasing burden of neurological disorders, the growing incidence of traumatic brain injuries, and the increasing number of product approvals. For instance, as per the Indian Head Injury Foundation’s 2022 data, over one million head injuries occur annually in India. The high number of head injuries is accelerating the demand for neurology monitoring devices.
The high prevalence rate of neurogenerative disorders like Parkinson’s and Alzheimer’s disease is expected to boost the market growth over time. According to Parkinson’s News Today, published in 2021, an estimated 7 to 10 million people worldwide have Parkinson’s disease. Approximately 60,000 Americans are diagnosed with this disease, thus, leading to a promising growth of the market studied. Since Parkinson’s disease is a progressive neurological disorder, its growing burden is expected to fuel the growth of the market over the forecast period. However, the high cost of monitoring devices is expected to restrain the market growth in some countries.
Neurology Monitoring Market Trends
Sleep Disorder is Expected to Witness Strong Growth Over the Forecast Period
Some of the most common sleep disorders include insomnia, restless legs syndrome, narcolepsy, and sleep apnea. Among these, insomnia affects a large population across the globe. Insomnia is a common sleep disorder that can make it hard to fall asleep, hard to stay asleep, can cause to wake up too early, and make it difficult to get back to sleep. People suffering from insomnia may still feel tired after waking up. The major factors bolstering the market growth are the high number of people suffering from insomnia, the implementation of strategic initiatives by the market players, and the growing focus on the research and development of neurofeedback systems for sleep disorders.
For instance, research data was published by PubMed in June 2021, comparing insomnia prevalence among 57,298 participants across 13 countries using the same methodology. The results revealed that out of the 57,298 participants, 11.3% had a diagnosis of short-term insomnia disorder, with significant differences in prevalence between sites, ranging from 2.3% to 25.5%. Thus, studies indicate that the need for neurofeedback systems for insomnia is increasing, which is contributing to market growth.
Moreover, some market players are undertaking strategic initiatives that support market growth. For instance, in October 2021, Interaxon, a consumer neurotechnology and meditation company, launched the second generation of its popular EEG meditation and sleep headband, Muse S. This updated plush brain-sensing headband uses real-time biofeedback to help one learn the art of meditation and helps fall asleep, stay asleep, and go back to sleep if one awakens during the night. Thus, the abovementioned factors are likely to drive the growth of the segment during the forecast period.
North America is the Dominant Region in the Neurology Monitoring Market
The market for neurology monitoring in the North American region is expected to grow significantly during the forecast period owing to factors such as the rising incidence of brain-associated disorders, mild brain traumatic injuries, supportive reimbursement policies, and high healthcare spending. In addition, the increasing geriatric population, who are more prone to develop neurodegenerative disorders, is also contributing to market growth. For instance, according to the 2022 statistics published by the United Nations Population Fund, in the United States, a large proportion of the living population is aged between 15 and 64 years and accounts for 65% of the total population. In addition, as per the same source, 17% of the population is aged 65 years and above.
According to the StatPearls data published in January 2022, it was observed that approximately 1.7 million people in the US suffer from traumatic brain injury; adolescents between ages 15 and 19 years and adults aged 65 years and older are among the most likely to sustain a traumatic brain injury. According to the same source, traumatic brain injury affects approximately 500 people per 100,000 in the US annually. Thus, the growing burden of brain injuries in the country is expected to drive market growth significantly. According to the statistics published by the American Society of Clinical Oncology in February 2022, about 4,170 children under the age of 15 are expected to be diagnosed with a brain tumor in the United States by the end of 2022.
Furthermore, as stated by the National Institute of Health, the funding for neurodegenerative diseases was USD 4,021 million in 2020 and increased to an estimated USD 4,110 million in 2021. The rising funding for research is expected to attract most of the major players, thus, leading to the high growth of the market studied.
Neurology Monitoring Market Competitor Analysis
The global neurology monitoring market is moderately competitive and fragmented, with the presence of major medical device companies in the market. Some of the key players in the market are Natus Medical Inc., Philips, Nihon Kohden Corporation, GE Healthcare, Drägerwerk, and Siemens Healthineers. The market players are focusing on R&D to develop technologically advanced products to reduce the cost and side effects associated with them.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Burden of Neurological Disorders
4.2.2 Growing Incidence of Traumatic Brain Injuries
4.2.3 Increasing Number of Product Approvals
4.3 Market Restraints
4.3.1 High Cost of Monitoring Devices
4.3.2 Shortage of Trained Professionals
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size – Value in USD million)
5.1 By Product Type
5.1.1 Magnetic Resonance Imaging (MRI) Devices
5.1.2 Electroencephalography devices
5.1.3 Cerebral Oximeters
5.1.4 Intracranial Pressure Monitors
5.1.5 Other Product Types
5.2 By Disease Type
5.2.1 Traumatic Brain Injury (TBI)
5.2.2 Stroke
5.2.3 Sleep Disorders
5.2.4 Parkinson’s Disease
5.2.5 Epilepsy
5.2.6 Other Diseases
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Natus Medical Inc.
6.1.2 Nihon Kohden Corporation
6.1.3 Philips Healthcare
6.1.4 GE Healthcare
6.1.5 Siemens Healthineers
6.1.6 Compumedics Limited
6.1.7 Medtronic PLC
6.1.8 Advanced Brain Monitoring Inc.
6.1.9 Dragerwerk Ag & Co. KGaA
6.1.10 Masimo Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS